docShepherd

docShepherd

Uncategorized

How the FDA approved an antipsychotic that failed to show a meaningful benefit but raised the risk of death | The BMJ

Bydashephe

Aug 31, 2023

By dashephe

Related Post

Uncategorized

Assessment of Behavioral/Psychological Symptoms of Dementia Guidelines and Implementation | Psychiatry Online

Nov 20, 2024 dashephe
Uncategorized

Pain Assessment Information | GeriatricPain.org – The University of Iowa

Nov 20, 2024 dashephe
Uncategorized

Gabapentinoids Tied to Hip Fractures in Older Adults | MedPage Today

Nov 14, 2024 dashephe

You missed

CMS Regulations

Surveyor Guidance Update 11-18-24

November 20, 2024 dashephe
Uncategorized

Assessment of Behavioral/Psychological Symptoms of Dementia Guidelines and Implementation | Psychiatry Online

November 20, 2024 dashephe
Uncategorized

Pain Assessment Information | GeriatricPain.org – The University of Iowa

November 20, 2024 dashephe
C auris Infxn Control

Candida auris outbreak in a long-term acute care hospital | November 15, 2024

November 16, 2024 dashephe